Improving Report of the ADAURA Trial by Distinguishing Treatment-Related Adverse Events From Treatment-Emergent Adverse Events and Assessing Independence of Censoring in Final Disease-Free Survival Analyses.

Wu, Danna; Li, Guo-Fu

Wu, Danna; Li, Guo-Fu.

Afiliación

Wu D; Danna Wu, MSc, Department of Pharmacy, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, Hainan, China; Guo-Fu Li, PhD, Guo Yu's Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China, Subei People's Hospital, Yangzhou, China.
Li GF; Danna Wu, MSc, Department of Pharmacy, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, Hainan, China; Guo-Fu Li, PhD, Guo Yu's Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China, Subei People's Hospital, Yangzhou, China.

J Clin Oncol ; 41(26): 4317-4318, 2023 09 10.

Article en En | MEDLINE | ID: mdl-37390376

Asunto(s)

Ensayos Clínicos como Asunto; Supervivencia sin Enfermedad; Humanos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos Clínicos como Asunto / Supervivencia sin Enfermedad Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google